Niva Bupa Health Insurance Company quarterly results

Q4 FY26 · Jan–Mar 2026

₹ crore	Q4 FY26	Q4 FY25	Change
EBITDA	366	263	+39.4%
Profit before tax	341	206	+65.5%
Net profit	345	206	+67.5%
EPS	₹1.87	₹1.13	+65.5%

Every quarter

₹ crore except per share

Tap a line for its trend	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025

Expenses
	−24.8	6.6	17.9	1.6	−56.5
	366	−94.3	−53.2	−93.0	263
	366	−94.3	−53.2	−93.0	263
Profit
	341	−87.6	−35.3	−91.4	206
	345	−87.6	−35.3	−91.4	206
Per share
	₹1.87	−₹0.47	−₹0.19	−₹0.50	₹1.13
Revenue detail — as filed
	2,078	1,550	1,538	1,308	1,565
	130	89.3	98.1	86.8	93.8
Expense detail — as filed
	155	189	165	166	142
	370	318	280	260	296
	370	318	280	260	296
	−21.8	20.2	27.2	10.5	−49.7
	−5.2	5.3	2.4	2.0	−1.3
Profit build-up — alternate / pre-Ind-AS tags
	341	−87.6	−35.3	−91.4	206
	341	−87.6	−35.3	−91.4	206
	−4.0	0.0	0.0	0.0	0.0
	345	−87.6	−35.3	−91.4	206
	−588	−933	−845	−810	−718
Per share — as-filed variants
	₹1.87	−₹0.47	−₹0.19	−₹0.50	₹1.13
	₹1.87	−₹0.47	−₹0.19	−₹0.50	₹1.13
Appropriations & transfers
	283	−136	−62.0	−145	94.9
	1,372	1,024	1,110	1,143	1,231
Insurance — revenue account (Policyholders')
	1,972	1,454	1,422	1,220	1,527
	2,880	2,231	1,843	1,632	2,079
	2,302	1,767	1,450	1,288	1,672
	306	317	308	244	313
	−16.6	14.9	24.7	8.4	−48.4
	1,052	946	961	850	825
	1,119	1,051	1,013	950	862
	66.9	104	51.7	100	37.0
Insurance — Shareholders' account
	319	−67.5	−8.1	−81.0	156
	36.1	68.1	53.9	64.2	49.6
	283	−136	−62.0	−145	94.9
	−0.0	0.0	0.0	0.0	0.0
	0.0	0.0	0.0	0.0	0.0
Insurance — result & transfers
	177	−231	−178	−234	57.6
	283	−136	−62.0	−145	94.9
	0.7	−0.1	0.0	−0.0	11.9
Insurance — fund NPAs
	50.0	50.0	50.0	50.0	54.3
	₹0.01	₹0.01	₹0.01	₹0.01	₹0.01
Insurance — IRDAI ratios (as filed, not percentages)
	2.49×	2.49×	2.85×	2.86×	3.03×
	₹2.49	₹2.49	₹2.85	₹2.86	₹3.03
	₹0.86	₹1.08	₹1.12	₹1.17	₹0.93
	₹0.57	₹0.72	₹0.71	₹0.78	₹0.56
	₹0.80	₹0.79	₹0.79	₹0.79	₹0.80
	₹0.28	₹0.33	₹0.39	₹0.38	₹0.36
Regulatory disclosures — filed alongside, not part of the P&L
	₹0.00	₹0.00	₹0.00	−₹1.00	−₹4.00
	₹0.00	₹0.00	₹0.00	₹0.00	₹14.00
	₹0.00	₹0.00	₹0.00	₹1.00	₹18.00
	7.4	—	—	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

NIVABUPA₹72.82

Niva Bupa Health Insurance Company Ltd.

· Banking & Finance

Annual Quarterly₹ CrorePeersSTARHEALTH ICICIGI NIACL SAMMAANCAP SBFC J&KBANK IEX HOMEFIRSTMcap ₹13,413 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026
Other Income	-56.5	1.6	17.9	6.6	-24.8
Expenses
EBITDA	262.6	-93.0	-53.2	-94.3	365.9
EBIT	262.6	-93.0	-53.2	-94.3	365.9
Profit
Pretax Income	206.1	-91.4	-35.3	-87.6	341.2
Net Income	206.1	-91.4	-35.3	-87.6	345.1
Per Share
Basic EPS	1.13	-0.50	-0.19	-0.47	1.87
Revenue Detail — as filed
+ Operating Income	1,564.7	1,308.4	1,538.1	1,549.5	2,077.7
+ Income from Investments (net)	93.8	86.8	98.1	89.3	130.5
Expense Detail — as filed
+ Employee Remuneration & Welfare	142.3	166.2	165.5	188.9	154.7
+ Commission (net)	295.5	259.8	279.8	317.6	369.5
+ Commission & Brokerage (net)	295.5	259.8	279.8	317.6	369.5
+ Non-operating Expense	-49.7	10.5	27.2	20.2	-21.8
+ Non-operating Provision — Doubtful Debts	-1.3	2.0	2.4	5.3	-5.2
Profit Build-up — Alternate / Pre-Ind-AS Tags
Profit before Extraordinary Items	206.1	-91.4	-35.3	-87.6	341.2
Profit / (Loss) before Tax — alt tag	206.1	-91.4	-35.3	-87.6	341.2
+ Provision for Tax	0.0	0.0	0.0	0.0	-4.0
Profit / (Loss) after Tax	206.1	-91.4	-35.3	-87.6	345.1
Profit Carried to Balance Sheet	-718.5	-809.9	-845.2	-932.8	-587.7
Per Share — as-filed variants
Basic & Diluted EPS before Extraordinary (not annualised)	1.13	-0.50	-0.19	-0.47	1.87
Basic & Diluted EPS after Extraordinary (not annualised)	1.13	-0.50	-0.19	-0.47	1.87
Appropriations & Transfers
+ Transfer to Profit & Loss Account	94.9	-145.2	-62.0	-135.5	282.5
Reserves & Surplus excl. Revaluation Reserve	1,231.3	1,142.6	1,110.0	1,024.2	1,371.5
Insurance — Revenue Account (Policyholders')
Premium Earned	1,527.4	1,220.0	1,422.1	1,453.6	1,972.0
+ Gross Premiums Written	2,078.7	1,631.9	1,843.1	2,231.3	2,879.7
+ Net Premium Written	1,672.1	1,287.9	1,450.1	1,766.7	2,301.7
+ Operating Expenses — Insurance Business	312.7	243.9	307.7	316.6	306.4
+ Non-operating Expenses — Non-insurance	-48.4	8.4	24.7	14.9	-16.6
+ Claims Paid	824.6	849.6	960.8	946.4	1,052.3
+ Incurred Claims	861.6	949.9	1,012.6	1,050.9	1,119.2
+ Change in Outstanding Claims	37.0	100.4	51.7	104.5	66.9
Insurance — Shareholders' Account
+ Income — Shareholders' Account	156.4	-81.0	-8.1	-67.5	319.4
+ Shareholders' Investment Income	49.6	64.2	53.9	68.1	36.1
+ Transfer from Policyholders' Fund	94.9	-145.2	-62.0	-135.5	282.5
With Unrealised Gains	0.0	0.0	0.0	0.0	-0.0
Without Unrealised Gains	0.0	0.0	0.0	0.0	0.0
Insurance — Result & Transfers
Underwriting Profit / (Loss)	57.6	-233.6	-178.0	-231.5	176.8
Operating Profit / (Loss)	94.9	-145.2	-62.0	-135.5	282.5
+ Other Income — Shareholders' Account	11.9	-0.0	0.0	-0.1	0.7
Insurance — Fund NPAs
+ Gross NPAs — Policyholders' Fund	54.3	50.0	50.0	50.0	50.0
+ Gross NPA % — Policyholders' Fund	0.01	0.01	0.01	0.01	0.01
Insurance — IRDAI Ratios (as filed, not percentages)
Solvency Ratio (x, one scale)	3.03	2.86	2.85	2.49	2.49
Solvency Ratio (as filed)	3.03	2.86	2.85	2.49	2.49
Combined Ratio	0.93	1.17	1.12	1.08	0.86
Incurred Claim Ratio	0.56	0.78	0.71	0.72	0.57
Net Retention Ratio	0.80	0.79	0.79	0.79	0.80
Expenses of Management Ratio	0.36	0.38	0.39	0.33	0.28
Regulatory Disclosures — filed alongside, not part of the P&L
Investor Complaints — During the Period	-4.00	-1.00	0.00	0.00	0.00
Investor Complaints — Received	14.00	0.00	0.00	0.00	0.00
Investor Complaints — Disposed	18.00	1.00	0.00	0.00	0.00
Related-party Transactions — During the Period	—	—	—	—	7.4
Other Filed Concepts — mapped but not yet placed in the schedule
Operating Expenses	1,469.8	1,453.6	1,600.1	1,685.1	1,795.1
Other Operating Expenses	170.4	77.7	142.2	127.7	151.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q4 FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.